Efficacy, Safety, and Tolerability of Remlarsen (MRG-201) Following Intradermal Injection in Subjects With a History of Keloids
Clinical trial NCT03601052 · COMPLETED
Trial details
- NCT number
- NCT03601052
- Sponsor
- miRagen Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-11
- Primary completion
- 2020-06-24
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.